ROG CH0012032048

Report

Delayed Swiss Exchange - 09/27 11:30:40 am
337.55	CHF		-0.84%

07:19a	GILEAD SCIENCES : Pfizer begins study of oral drug for prevention of COVID-19	RE
09/24	ROCHE : Muscular Disease Therapies Show Efficacy In Various Studies	MT
09/24	PRESS RELEASE : Roche presents new data at World -2-	DJ

Summary

Quotes 5-day view Delayed Quote.

Delayed Swiss Exchange

09/21/2021	09/22/2021	09/23/2021	09/24/2021	09/27/2021	Date
339.35(c)	340.05(c)	342.6(c)	340.4(c)	337.55	Last
1 134 706	1 156 295	1 568 475	872 454	1 081 891	Volume
-0.63%	+0.21%	+0.75%	-0.64%	-0.84%	Change

More quotes

Estimated financial data (e)

Sales 2021	61 371 M 66 291 M 66 291 M
Net income 2021	14 747 M 15 929 M 15 929 M
Net cash position 2021	4 290 M 4 634 M 4 634 M
P/E ratio 2021	19,8x
Yield 2021	2,76%

Sales 2022	62 028 M 67 000 M 67 000 M
Net income 2022	15 426 M 16 663 M 16 663 M
Net cash position 2022	11 414 M 12 329 M 12 329 M
P/E ratio 2022	19,0x
Yield 2022	2,86%

Capitalization	298 B 322 B 321 B
EV / Sales 2021	4,78x
EV / Sales 2022	4,61x
Nbr of Employees	101 465
Free-Float	83,5%

More Financials

Company

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The...

Sector

Pharmaceuticals

Calendar

09/28

Presentation

More about the company

Ratings of Roche Holding AG

Trading Rating :

Investor Rating :

ESG Refinitiv :

B+

More Ratings

All news about ROCHE HOLDING AG

07:19a	GILEAD SCIENCES : Pfizer begins study of oral drug for prevention of COVID-19	RE
09/24	ROCHE : Muscular Disease Therapies Show Efficacy In Various Studies	MT
09/24	PRESS RELEASE : Roche presents new data at World -2-	DJ
09/24	PRESS RELEASE : Roche presents new data at World Muscle Society (WMS) 2021 highlighting ne..	DJ
09/24	ROCHE : presents new data at World Muscle Society (WMS) 2021 highlighting new advances for..	AQ
09/23	ROCHE : WHO Recommends Roche-Regeneron COVID-19 Antibody Cocktail For High-Risk Patients	MT
09/23	REGENERON PHARMACEUTICALS : WHO backs Regeneron COVID-19 drug cocktail as UN body calls fo..	RE
09/23	ROCHE HOLDINGS AG : Credit Suisse gives a Neutral rating	MD
09/23	ROCHE : Canadian Blood Services selects Roche Diagnostics Canada as a partner of choice fo..	AQ
09/22	ROCHE : Joins CG Oncology to Study Novel Immunotherapy Combination in Cancer Patients	MT
09/22	ROCHE : Rolls Out Three Respiratory Tests On Cobas 6800/8800 Systems	MT
09/22	PRESS RELEASE : Roche launches three respiratory -2-	DJ
09/22	ROCHE : launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to..	AQ
09/22	PRESS RELEASE : Roche launches three respiratory test panels on cobas 6800/8800 Systems in..	DJ
09/22	Roche Launches Three Respiratory Test Panels on Cobas 6800/8800 Systems in CE Markets t..	CI

More news

News in other languages on ROCHE HOLDING AG

09/25	Pharmakonzern Roche feiert 125-Jahr-Jubiläum mit Lichtspektakel
09/24	MERCK, ROCHE, SHIONOGI : la course aux traitements Covid sous forme de pilule
09/24	PLANÈTE BOURSE : La revue de presse du vendredi 24 septembre 2021
09/24	Les traitements de Roche contre les maladies musculaires se révèlent efficaces dans div..
09/24	Roche kündigt neue Evrysdi- und SRP-9001-Daten für Fachkongress an

More news

Analyst Recommendations on ROCHE HOLDING AG

09/23	ROCHE HOLDINGS AG : Credit Suisse gives a Neutral rating	MD
09/20	ROCHE HOLDINGS AG : JP Morgan gives a Neutral rating	MD
09/17	ROCHE HOLDINGS AG : JP Morgan gives a Neutral rating	MD

More recommendations

Provided by Scoopnest.com

Analysis

China's biotech sector comes of age with big licensing deals, global ambitions